Enzo Biochem Inc (ENZB)

Currency in USD
0.699
+0.011(+1.60%)
Closed·
Showing Enzo Biochem historical data. For real-time data please try another search
Day's Range
0.6900.699
52 wk Range
0.2521.129
Key Statistics
Prev. Close
0.699
Open
0.69
Day's Range
0.69-0.699
52 wk Range
0.252-1.129
Volume
361.75K
Average Volume (3m)
368.87K
1-Year Change
-32.79%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock

Enzo Biochem Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Enzo Biochem Inc Company Profile

Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally. The company offers labels, dyes, antibodies, genomic probes, immunoassays, biochemicals, and proteins are used to label, detect, and visualize a biological target of interest in drug discovery exploration and drug development process development. Its proprietary products and technologies play roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. The company licenses its technology. It serves academic researchers, clinical researchers, biotechnology and pharmaceutical companies, and diagnostic manufacturers. Enzo Biochem, Inc. was incorporated in 1976 and is headquartered in Farmingdale, New York. As of August 20, 2025, Enzo Biochem, Inc. was taken private.

Employees
131

Compare ENZB to Peers and Sector

Metrics to compare
ENZB
Peers
Sector
Relationship
P/E Ratio
0.0x0.0x0.0x
PEG Ratio
0.000.000.00
Price/Book
0.0x0.0x0.0x
Price / LTM Sales
0.0x0.0x0.0x
Upside (Analyst Target)
0.0%0.0%0.0%
Fair Value Upside
Unlock0.0%0.0%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -0.15%
Dividend Yield
57.24%
Industry Median 2.90%
Annualised payout
0.40
Paid quarterly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Jun 16, 2025
EPS / Forecast
-0.05 / --
Revenue / Forecast
6.40M / --
EPS Revisions
Last 90 days

ENZB Income Statement

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.